HTTP/2 200 date: Thu, 06 Aug 2020 14:02:02 GMT content-type: text/html; charset=UTF-8 set-cookie: __cfduid=deefba6674a288da1ab4c4c3f5377b24a1596722522; expires=Sat, 05-Sep-20 14:02:02 GMT; path=/; domain=.drugpatentwatch.com; HttpOnly; SameSite=Lax strict-transport-security: max-age=31536000 x-frame-options: SAMEORIGIN x-content-type-options: nosniff cf-cache-status: DYNAMIC cf-request-id: 0465ad410b000040ec4a319200000001 expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" server: cloudflare cf-ray: 5be94b14d9a740ec-HAM
[DrugPatentWatch]
[ Log In] [Blog] [Newsletter] [Contact] [Start Trial][Pricing]
Serving leading biopharmaceutical companies globally:
Trying to source investigational COVID-19 Drugs? [See our COVID-19 Resource Page]
Make Better Decisions
… around branded drug lifecycle management and generic entry
with accurate, objective, and timely intelligence
DrugPatentWatch cited by CNN, NEJM, Nature Journals, and more …
Solutions designed for all your needs
Reliable primary data + expert analysis. We provide answers for your burning questions
[See Plans and Pricing →]
Generic First Entrants
How do we identify generic entrants before they get FDA approval?
[Read Article]
Pharmaceutical Business Development
Identify clients for API, research tools, and patent litigation support.
[Read Article]
Day 181 Generic Drug Launch
A Fast and Cheap Way to Find Generic Entry Opportunities
[Read Article]
Find and Evaluate Business Opportunities
Assess levels of generic competition Use drug price ranges to evaluate price elasticity Determine optimal prices before launch
Get Confidential Royalty and Settlement Terms
Study failed patent challenges to develop a better strategy Collect competitive intelligence by examining contractual disputes Track litigation to anticipate early generic entry
Global Drug Patents
Drug Patents in 134 Countries Evaluate branded and generic market opportunities globally
Refine Your Market-Entry Strategy
Assess market potential through historic sales figures Evaluate buyer power with data on reimbursement segmentation Align distribution methods with information on where and how drugs are purchased
Monitor 505(b)(2) and biosimilar activity
Anticipate 505(b)(2) and biosimilar approvals Track OTC-switches, new formulations, biosimilars, and other drug improvements Strengthen new formulation patents by studying prior claims and litigation
Find Generic Drug Entry Opportunities
Inform portfolio management decisions Sector landscaping and due diligence Track drugs in development and explore new indications for existing drugs
Serving leading biopharmaceutical companies globally:
×
Get the DrugPatentWatch Daily Briefing
Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
✓ Patent Expirations and Generic Entry ✓ Insightful Articles and Case Studies ✓ Patent Litigation & Challenges ✓ 505(b)(2) & Biosimilars ✓ Industry Trends [➤ Get the Daily Briefing]
×
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
Visit the [Subscription Options] page for details on plans and pricing.
[ ]
Copyright 2002-2020 [thinkBiotech LLC]
ISSN: 2162-2639
[Privacy and Cookies]
[Terms & Conditions]
[Site Map]
[DrugPatentWatch Alternatives]
[LOE / Major Patent Expirations 2020 - 2021]
[NCE-1 Patent Challenge Dates 2020 - 2021]
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2020, [www.DrugPatentWatch.com].
Links
[About] [Blog] [Coaching for Consultants] [Contact] [Database Preview] [Partner Affiliate Program] [Pricing]
Follow DrugPatentWatch:
[] []
By using our website you are consenting to our use of cookies in accordance with our [privacy policy]. I agree
×
Access the Complete Database
BioPharmaceutical Business Intelligence
Uncover prior art in expired and abandoned patents Obtain formulation and manufacturing information Drug patents in 130+ countries [➤ Start Trial]
or, [see Plans & Pricing]
